Status: current, Defined. Date: 31-Oct 2015. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1458011000168114 | Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1458021000168119 | Duodopa intestinal gel | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel (trade product unit of use) | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel (trade product unit of use) | Is a | Duodopa | true | Inferred relationship | Some | ||
| Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel (trade product unit of use) | Is a | levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel | true | Inferred relationship | Some | ||
| Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel (trade product unit of use) | has unit of use | continuous | true | Inferred relationship | Some | 1905675209 | |
| Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel (trade product unit of use) | has Australian BoSS | levodopa | true | Inferred relationship | Some | 635527130 | |
| Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel (trade product unit of use) | has manufactured dose form | intestinal gel | true | Inferred relationship | Some | ||
| Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel (trade product unit of use) | has intended active ingredient | levodopa | true | Inferred relationship | Some | 635527130 | |
| Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel (trade product unit of use) | has intended active ingredient | carbidopa | true | Inferred relationship | Some | 1905675208 | |
| Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel (trade product unit of use) | has Australian BoSS | carbidopa monohydrate | true | Inferred relationship | Some | 1905675208 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Duodopa intestinal gel, 100 mL | has TPUU | True | Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel (trade product unit of use) | Inferred relationship | Some | 1 |
| Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel, 7 x 100 mL (trade product pack) | has TPUU | True | Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel (trade product unit of use) | Inferred relationship | Some | 2 |
| Duodopa intestinal gel, 100 mL, bag | has TPUU | True | Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel (trade product unit of use) | Inferred relationship | Some | 1 |
| Duodopa intestinal gel, 7 x 100 mL, bags | has TPUU | True | Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel (trade product unit of use) | Inferred relationship | Some | 2 |
Reference Sets
Australian dialect reference set
Description inactivation indicator reference set
Trade product unit of use reference set
FHIR